During the past decade, Cardiovascular Associates conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiovascular Associates" #1 collaborator was "Beth Israel Deaconess Medical Center" with 1 trials as a collaborator, "ClinLogix. LLC" with 1 trials as a collaborator, "Massachusetts General Hospital" with 1 trials as a collaborator and "Medtronic" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Cardiovascular Associates" are "Bradycardia" (1 trials), "Femoral Artery Occlusion" (1 trials), "Femoral Artery Stenosis" (1 trials), "Heart Failure, Congestive" (1 trials) and "Peripheral Arterial Disease" (1 trials). Many other conditions were trialed in "Cardiovascular Associates" in a lesser frequency.

Most popular intervention types in "Cardiovascular Associates" are "Device" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lutonix Drug Coated Balloon" (1 trials), "Misago™ Self-Expanding Stent System" (1 trials), "Moxy Drug Coated Balloon" (1 trials), "Standard Uncoated Angioplasty Balloon" (1 trials) and "Stenting of the Common and/or External Iliac Arteries" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiovascular Associates" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Cardiovascular Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Cardiovascular Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiovascular Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".